GDF5 Human

Growth Differentiation Factor-5 Human Recombinant
Cat. No.
BT18292
Source
Escherichia Coli.
Synonyms
Cartilage-derived morphogenetic protein-1, CDMP-1, LAP4, SYNS2, GDF-5, Radotermin, CDMP1, GDF5, Growth differentiation factor 5, BMP-14.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 98.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Growth Differentiation Factor 5 Human Recombinant produced in E.Coli is a homodimer, non-glycosylated polypeptide chain containing 2 x 120 amino acids and having a total molecular mass of 27.4kDa. To enable bacterial expression the N-terminal sequence of Ala-Pro-Leu-Thr was replaced with a Lys.
GDF5 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Growth Differentiation Factor 5 (GDF-5), a protein belonging to the bone morphogenetic protein (BMP) family within the TGF-beta superfamily, plays a crucial role in regulating cell growth and differentiation in both embryonic and adult tissues. GDF-5 is synthesized as a precursor protein that undergoes proteolytic processing to release a mature protein containing seven conserved cysteine residues. This mature protein is involved in skeletal development, as evidenced by the association of GDF-5 gene mutations with skeletal dysplasias like acromesomelic dysplasia, Hunter-Thompson type; brachydactyly, type C; and chondrodysplasia, Grebe type.
Description
Recombinant Human Growth Differentiation Factor 5, expressed in E. coli, is a non-glycosylated homodimeric protein. Each subunit comprises 120 amino acids, resulting in a total molecular mass of 27.4 kDa. To facilitate bacterial expression, the N-terminal sequence has been modified by replacing the original Ala-Pro-Leu-Thr sequence with Lys. The protein undergoes purification using proprietary chromatographic techniques.
Physical Appearance
White, lyophilized powder, sterile-filtered.
Formulation
The lyophilized Growth Differentiation Factor 5 is supplied without any additional additives.
Solubility
To reconstitute the lyophilized Growth Differentiation Factor-5, it is recommended to dissolve it in sterile 18 MΩ-cm H2O at a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized Growth Differentiation Factor 5 remains stable at room temperature for up to 3 weeks; however, it is recommended to store it desiccated at a temperature below -18°C. After reconstitution, Growth Differentiation Factor-5 should be stored at 4°C for a period of 2-7 days. For long-term storage, it is advisable to store it below -18°C. The addition of a carrier protein such as HSA or BSA (0.1%) is recommended for long-term storage. It is important to avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 98.0% through the following methods:
(a) Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis.
(b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis.
Biological Activity
The biological activity of GDF-5 is determined by its ability to induce alkaline phosphatase activity in ATDC5 cells. Typically, the activity is observed at concentrations of 10-20 ng/ml.
Protein Content
Protein quantification was performed using two independent methods:
1. UV spectroscopy at 280 nm, utilizing an absorbance value of 1.15 as the extinction coefficient for a 0.1% (1 mg/ml) solution. This value was determined using the PC GENE computer analysis program (IntelliGenetics) for protein sequence analysis.
2. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis, employing a standard solution of GDF5 as a reference standard.
Synonyms
Cartilage-derived morphogenetic protein-1, CDMP-1, LAP4, SYNS2, GDF-5, Radotermin, CDMP1, GDF5, Growth differentiation factor 5, BMP-14.
Source
Escherichia Coli.
Amino Acid Sequence
APSATRQGKR PSKNLKARCS RKALHVNFKD MGWDDWIIAP LEYEAFHCEG LCEFPLRSHL EPTNHAVIQT LMNSMDPEST PPTCCVPTRL SPISILFIDS ANNVVYKQYE DMVVESCGCR.

Product Science Overview

Structure and Function

GDF-5 is synthesized as a precursor protein that undergoes proteolytic cleavage to produce a mature protein containing seven conserved cysteine residues . The mature GDF-5 protein forms a disulfide-linked homodimer, which is essential for its biological activity . The molecular weight of the recombinant human GDF-5 protein is approximately 27.4 kDa .

Biological Role

GDF-5 plays a critical role in the development of bones, joints, and limbs . It binds to a receptor complex comprising BMPR1B and BMPR2, which then activates the SMAD signaling pathway . This signaling pathway is crucial for the regulation of gene expression involved in bone and cartilage formation.

Clinical Significance

Alterations in the expression of GDF-5 have been linked to various skeletal disorders. For instance, decreased or altered expression of GDF-5 is associated with the pathogenesis of osteoarthritis and certain forms of dwarfism . Additionally, GDF-5 has been implicated in the development of Parkinson’s disease .

Recombinant GDF-5

Recombinant human GDF-5 is produced using Escherichia coli (E. coli) expression systems . The recombinant protein is typically supplied in a lyophilized form and requires reconstitution before use . It is highly purified, with endotoxin levels kept below 1 EU per microgram .

Applications

Recombinant GDF-5 is widely used in research to study its role in bone and cartilage development. It is also used in various therapeutic applications, including the treatment of bone fractures and cartilage injuries .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.